Quantum Research Development from 2010 to 2026
| QNTM Stock | 3.55 0.03 0.84% |
Research Development | First Reported 2020-03-31 | Previous Quarter 549.2 K | Current Value 495.2 K | Quarterly Volatility 1.2 M |
Check Quantum BioPharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quantum BioPharma's main balance sheet or income statement drivers, such as Selling General Administrative of 13.3 M, Other Operating Expenses of 19.3 M or Total Operating Expenses of 19.1 M, as well as many indicators such as Price To Sales Ratio of 4.4 K, Dividend Yield of 0.0 or PTB Ratio of 0.34. Quantum financial statements analysis is a perfect complement when working with Quantum BioPharma Valuation or Volatility modules.
Quantum | Research Development | Build AI portfolio with Quantum Stock |
Evaluating Quantum BioPharma's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Quantum BioPharma's fundamental strength.
Latest Quantum BioPharma's Research Development Growth Pattern
Below is the plot of the Research Development of Quantum BioPharma over the last few years. It is Quantum BioPharma's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quantum BioPharma's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Quantum Research Development Regression Statistics
| Arithmetic Mean | 7,045,892 | |
| Geometric Mean | 6,917,026 | |
| Coefficient Of Variation | 17.82 | |
| Mean Deviation | 1,018,413 | |
| Median | 7,832,847 | |
| Standard Deviation | 1,255,893 | |
| Sample Variance | 1.6T | |
| Range | 4M | |
| R-Value | (0.77) | |
| Mean Square Error | 687.4B | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | (191,266) | |
| Total Sum of Squares | 25.2T |
Quantum Research Development History
About Quantum BioPharma Financial Statements
Quantum BioPharma investors utilize fundamental indicators, such as Research Development, to predict how Quantum Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 5.5 M | 5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Quantum BioPharma Correlation against competitors. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Biotechnology sector continue expanding? Could Quantum diversify its offerings? Factors like these will boost the valuation of Quantum BioPharma. Anticipated expansion of Quantum directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Quantum BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Quantum BioPharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Quantum BioPharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Quantum BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.